Opgen Inc (OPGN) |
|
2.29 -0.32 (-12.26%)
|
08-13 16:00 |
|
Open: |
2.46 |
Pre. Close: |
2.61 |
|
High:
|
2.47 |
Low:
|
2.2 |
|
Volume:
|
4,398,772 |
Market Cap:
|
35M |
|
|
|
|
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services in the United States and internationally. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include Acuitas AMR Gene Panel, a vitro diagnostic test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance in urine specimens or bacterial colonies isolated from urine and other body sites; and QuickFISH and PNA FISH products, which are FDA-cleared and CE-marked diagnostic test designed to detect pathogens in positive blood cultures. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.473 - 2.485 |
2.485 - 2.497 |
|
Low:
|
2.168 - 2.181 |
2.181 - 2.195 |
|
Close:
|
2.264 - 2.286 |
2.286 - 2.308 |
|
Technical analysis |
as of: 2020-08-13 4:37:03 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 4.04 One year: 5.19 |
| Support: |
Support1: 1.88 Support2: 1.56 |
| Resistance: |
Resistance1: 3.46 Resistance2: 4.44 |
| Pivot: |
2.39  |
| Moving Average: |
MA(5): 2.79 MA(20): 2.36
MA(100): 2.21 MA(250): 2.80 |
| MACD: |
MACD(12,26): 0.13 Signal(9): 0.12 |
| Stochastic oscillator: |
%K(14,3): 18.95 %D(3): 30.29 |
| RSI: |
RSI(14): 48.83 |
| 52-week: |
High: 12.80 Low: 0.92 Change(%): -56.6 |
| Average Vol(K): |
3-Month: 555353 10-Days: 2475782 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.OPGN has closed above bottom band by 43.2%. Bollinger Bands are 141% wider than normal. The large width of the bands suggest high volatility as compared to OPGN's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
Thu, 13 Aug 2020
OpGen Inc. (OPGN) went up 1.95% yesterday: Is this the Most Sought-After Stock Today? - News Daemon
Wed, 12 Aug 2020
OpGen, Inc. (OPGN) CEO Oliver Schacht on Q2 2020 Results - Earnings Call Transcript - Seeking Alpha
Tue, 11 Aug 2020
A Preview Of OpGen's Earnings - Yahoo Finance
Tue, 11 Aug 2020
OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers - Yahoo Finance
Mon, 10 Aug 2020
OPGN Stock Price: OpGen Inc. price boomerangs as shares close lower after hot start - FXStreet
Mon, 10 Aug 2020
OpGen Inc. (OPGN) can’t be written off after posting last 3-months Average volume of 4.83M - The InvestChronicle
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ Capital Market |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
15 |
| Shares Float (M) |
15 |
|
% Held by Insiders
|
13.76 |
|
% Held by Institutions
|
6.84 |
|
Shares Short (K)
|
1,160 |
|
Shares Short P. Month (K)
|
862 |
Stock Financials |
|
EPS
|
-3.747 |
|
EPS Est This Year
|
-0.420 |
|
EPS Est Next Year
|
-0.160 |
|
Book Value (p.s.)
|
1.130 |
|
Profit Margin
|
|
|
Operating Margin
|
-346.61 |
|
Return on Assets (ttm)
|
-42.1 |
|
Return on Equity (ttm)
|
-136.2 |
|
Qtrly Rev. Growth
|
-39.5 |
|
Gross Profit (p.s.)
|
-0.210 |
|
Sales Per Share
|
0.201 |
|
EBITDA (p.s.)
|
-0.634 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-11 |
|
Levered Free Cash Flow (M)
|
-10 |
Stock Valuations |
|
PE Ratio
|
-0.61 |
|
PEG Ratio
|
|
|
Price to Book value
|
2.03 |
|
Price to Sales
|
11.42 |
|
Price to Cash Flow
|
-3.26 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
